Growth Promotion and Increased ATP-Binding Cassette Transporters Expression by Liraglutide in Triple Negative Breast Cancer Cell Line MDA-MB-231
Conclusion In conclusion, these results suggest that liraglutide
should be used with caution in patients who are suffering or have the
personal history of triple negative breast cancer. However, more detailed
studies are required to deepen understanding of liraglutide consequences in
triple negative breast cancer. ▶Graphical Abstract.
[...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Drug Research - Category: Drugs & Pharmacology Authors: Shadboorestan, Amir Tarighi, Parastoo Koosha, Mahsa Faghihi, Homa Ghahremani, Mohammad Hossein Montazeri, Hamed Tags: Original Article Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Epithelial Cancer | Statistics | Study | Toxicology | Victoza